GSK Releases Population Projections for Key Diseases Through 2030

GSK plc, the global healthcare company, has published a detailed report outlining projected population figures for various diseases across key markets through 2030.

The "Epidemiology Report - Population Numbers Projected to 2030" covers a spectrum of conditions including shingles, Respiratory Syncytial Virus (RSV), influenza, pneumococcal disease, urinary tract infections, hepatitis B, HIV, severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and Chronic Obstructive Pulmonary Disease (COPD).

These projections are segmented by demographic, including age groups and treatment statuses, across the United States, Europe (EU5), China, and Japan. The data aims to provide insights into future healthcare needs and treatment demand on a global scale.

The report is intended to equip healthcare planners and other stakeholders with valuable data for resource allocation. Its release seeks to enhance understanding of the prevalence and future focus areas for these diverse health conditions.